BWAY Stock Analysis: Buy, Sell, or Hold?
BWAY - Brainsway Ltd. American Depositary Shares
$14.10
-0.96 (-6.37%)
▼
5d:
-11.99%
30d:
-0.35%
90d:
+1.29%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026
29d
Get Alerted When BWAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called BWAY this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BWAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BWAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.32
13.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BWAY is currently trading at $14.10, which is considered oversold relative to its 30-day fair value range of $14.19 to $15.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.9) compared to its historical average (50.9). Remarkably, the market is currently pricing in an annual earnings decline of 18.2% over the next few years. This pessimistic expectation contrasts with the company's recent 200% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BWAY is in a downtrend. The price is currently testing key support at $13.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: BWAY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.50 (+16.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BWAY is in a downtrend. The price is currently testing key support at $13.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: BWAY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.50 (+16.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.19 -
$15.17
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading below Wall St target ($17.50)
- CAUTION: 5-day price weakness (-12.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$14.19 -
$15.17
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.86
Resistance Level
$16.26
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.89
Wall Street Target
$17.50
(+16.2%)
Revenue Growth (YoY)
34.6%
Earnings Growth (YoY)
200.0%
Profit Margin
15.6%
Valuation Discount vs History
-18.2% cheaper
PE vs Historical
27.9 vs 50.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.2%
(market-implied from PE analysis)
1-Year Target
$13.55
(-10%)
2-Year Target
$12.20
(-19%)
3-Year Target
$10.98
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→51)
$20.04
(+33%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.9, Growth: 63.6%)
$50.83
(+238%)
Base:
(SPY PE: 21.8, Growth: 63.6%)
$39.69
(+164%)
Bear:
(PE: 18.5, Growth: 63.6%)
$33.74
(+124%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Forward PE: 35.84 | Forward EPS (Implied): $0.42
Bull Case
$18.18
(+21%)
Analyst growth 15.0%, PE expands to 37.6
Base Case
$15.06
(0%)
Market implied 0.0%, PE stable at 35.8
Bear Case
$11.52
(-24%)
Severe decline -15.0%, PE contracts to 32.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.9 to 50.9
Stabilization Target:
$27.49
(+82.5%)
PE Expansion Potential:
+82.5%
Share & Embed Analysis
Last updated: July 13, 2026 4:21 PM ET
Data refreshes hourly during market hours. Next update: 5:21 PM
Data refreshes hourly during market hours. Next update: 5:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BWAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 62 BUY |
